Dendreon Corp fka DNDNQ

[walldiver]

It's recent info. Remember that most of these cerebrovascular events took place many months after Provenge infusion, in a population cohort averaging ~72 years of age. What if some of these CVA events took place after the patients in question had passed the median survival point? Perhaps one can't definitively attribute these CVA events to the Provenge.

Edit: In addition, it appears that this CVA analysis might not take into account the fact that most in the placebo arms got Provenge as well. Were the two CVA events in the placebo arms crossover patients?